ChronoScale stock falls 2.03 percent after Ekso exit plan

ChronoScale stock was trading at USD 20.77 on Nasdaq on September 23, 2026 at 12:07 p.m. ET, down 2.03 percent from the previous close of USD 21.20. The move comes as the former Ekso Bionics owner reshapes its business around cloud operations.

Ekso exit targets fiscal 2027

ChronoScale's board committed on May 29, 2026, to divest the Legacy Ekso Business and concentrate future operations on the Cloud Business, according to StockTitan. The filing classifies the legacy operation as held for sale and discontinued operations, with completion expected during fiscal year 2027.

The transaction changes what the ticker represents. The combination with Applied Digital's cloud business closed on May 5, 2026, and the former Ekso issuer began trading on Nasdaq under CHRN, according to CMC Markets.

Revenue declines as losses narrow

Fiscal 2026 revenue was USD 71.6 million, down 15 percent from USD 84.4 million, while net loss narrowed to USD 50.3 million from USD 72.7 million. CMC Markets reported that the Cloud Business generated approximately 99.5 percent of total revenue, making the planned Ekso divestiture a decisive separation of the operating model.

The concentration also raises the importance of financing and execution. The fiscal 2026 revenue decline shows that the new cloud strategy had not yet translated into top-line expansion, even as the annual loss improved by USD 22.4 million.

Debt amendment sets November date

A September 12, 2026 Form 8-K identifies ChronoScale Holdings Corporation as the current parent, with common stock listed on the Nasdaq Capital Market under CHRN. The filing also states that a USD 2.0 million secured term loan now matures on November 12, 2026 and permits the sale of the Ekso Bionics guarantor under the amended agreement, according to the SEC filing.

Stock remains below yearly high

ChronoScale stock stood at USD 20.77 on Nasdaq on September 23, 2026, with a 52-week range of USD 3.50 to USD 30.00 and a market capitalization of USD 74,011,403. The stock was 30.77 percent below the yearly high, leaving the planned divestiture and the November debt date as the next concrete corporate milestones.